2nd Quarter - Report

AMERICAN CAPITOL GROUP for C-PATH INSTITUTE

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Reauthorization of the Critical Path Public Private Partnership Program. Food and Drug Safety and Innovations Act.

LobbyistCovered position, as disclosed
DAVE LARSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Budget/Appropriations BUD

FDA Appropriations for research projects related to FDA's Critical Path Public Private Partnership Program

LobbyistCovered position, as disclosed
DAVE LARSON —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.